Company intelligence / Profile preview

IPOS International

Ownership: Private
Development stage: Other

Overview

IPOS International provides intellectual property (IP) management and commercialization services. It operates as a wholly owned subsidiary of the Intellectual Property Office of Singapore (IPOS), focusing on helping organizations and innovators manage, protect, and commercialize their intangible assets. The company does not develop therapeutics or diagnostics.

Industry: Consulting

Partnerships

Collaborates with government agencies, research institutes, universities, and industry partners in Singapore for IP strategy and commercialization support.No major pharmaceutical or biotech partnerships reported.

Beyond the preview

Go deeper on IPOS International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPOS International.

Explore the full profile